[Herpesviruses and biomarkers in disseminated encephalomyelitis and multiple sclerosis in children].

Autor: Skripchenko EY; Pediatric Research and Clinical Center for Infectious Diseases, St. Petersburg, Russia.; Saint-Petersburg State Pediatric Medical University, St. Petersburg, Russia., Zheleznikova GF; Pediatric Research and Clinical Center for Infectious Diseases, St. Petersburg, Russia., Alekseeva LA; Pediatric Research and Clinical Center for Infectious Diseases, St. Petersburg, Russia., Skripchenko NV; Pediatric Research and Clinical Center for Infectious Diseases, St. Petersburg, Russia.; Saint-Petersburg State Pediatric Medical University, St. Petersburg, Russia., Astapova AV; Pediatric Research and Clinical Center for Infectious Diseases, St. Petersburg, Russia., Gorelik EY; Pediatric Research and Clinical Center for Infectious Diseases, St. Petersburg, Russia., Vilnitz AA; Pediatric Research and Clinical Center for Infectious Diseases, St. Petersburg, Russia.
Jazyk: ruština
Zdroj: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2021; Vol. 121 (3), pp. 138-145.
DOI: 10.17116/jnevro2021121031138
Abstrakt: The relevance of the study of demyelinating diseases is due to their increasing frequency in children, clarification of the role of infectious agents in their genesis, as well as the possibility of transformation of disseminated encephalomyelitis into multiple sclerosis. The literature review presents the currently available information on the causes of the development of demyelinating diseases, biomarkers of disseminated encephalomyelitis and multiple sclerosis, the causes of an unfavorable course and possible laboratory parameters indicating the transition from one disease to another, which can be used as prognostic factors. The authors also noted the experience of the authors on the importance of adequate etiopathogenetic therapy in changing the nature of the course of the disease, in particular, when confirming the relationship between the frequency of exacerbations of ADEM and MS with the activation of herpesvirus infections, courses of specific antiviral therapy are effective, as well as pathogenetic therapy aimed at correcting endothelial dysfunction using the drug cytoflavin.
Databáze: MEDLINE